Senzar Asset Management as of June 30, 2016
Portfolio Holdings for Senzar Asset Management
Senzar Asset Management holds 41 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eli Lilly & Co. (LLY) | 10.3 | $47M | 602k | 78.75 | |
| Sanofi-Aventis SA (SNY) | 10.1 | $46M | 1.1M | 41.85 | |
| Abbott Laboratories (ABT) | 6.7 | $31M | 779k | 39.31 | |
| Shire | 6.5 | $30M | 163k | 184.08 | |
| Biogen Idec (BIIB) | 5.3 | $25M | 102k | 241.82 | |
| Amgen (AMGN) | 5.2 | $24M | 156k | 152.15 | |
| Healthways | 4.6 | $21M | 1.8M | 11.55 | |
| Aetna | 4.3 | $20M | 163k | 122.13 | |
| Anthem (ELV) | 4.1 | $19M | 144k | 131.34 | |
| Universal Health Services (UHS) | 3.4 | $15M | 115k | 134.10 | |
| Centene Corporation (CNC) | 2.7 | $12M | 173k | 71.37 | |
| Laboratory Corp. of America Holdings (LH) | 2.5 | $11M | 87k | 130.27 | |
| Enanta Pharmaceuticals (ENTA) | 2.3 | $11M | 482k | 22.05 | |
| Endologix | 2.2 | $10M | 810k | 12.46 | |
| Acorda Therapeutics | 2.0 | $9.1M | 358k | 25.51 | |
| Concert Pharmaceuticals I equity | 2.0 | $9.0M | 801k | 11.23 | |
| Momenta Pharmaceuticals | 1.9 | $8.7M | 808k | 10.80 | |
| Alder Biopharmaceuticals | 1.8 | $8.5M | 339k | 24.97 | |
| Tesaro | 1.7 | $7.9M | 94k | 84.05 | |
| Insmed (INSM) | 1.7 | $7.8M | 789k | 9.86 | |
| Molina Healthcare (MOH) | 1.6 | $7.5M | 151k | 49.90 | |
| Halozyme Therapeutics (HALO) | 1.5 | $6.8M | 786k | 8.63 | |
| Corium Intl | 1.3 | $6.0M | 1.7M | 3.47 | |
| Retrophin | 1.3 | $5.9M | 330k | 17.81 | |
| Acadia Healthcare (ACHC) | 1.2 | $5.7M | 102k | 55.40 | |
| Intra Cellular Therapies (ITCI) | 1.2 | $5.6M | 145k | 38.82 | |
| K2m Group Holdings | 1.2 | $5.5M | 356k | 15.52 | |
| Tandem Diabetes Care | 1.0 | $4.6M | 615k | 7.54 | |
| Syneron Medical Ltd ord | 0.8 | $3.9M | 510k | 7.69 | |
| Foamix Pharmaceuticals | 0.8 | $3.8M | 598k | 6.35 | |
| Valeant Pharmaceuticals Int | 0.7 | $3.3M | 165k | 20.14 | |
| Inotek Pharmaceuticals | 0.7 | $3.3M | 445k | 7.44 | |
| Arena Pharmaceuticals | 0.7 | $3.2M | 1.9M | 1.71 | |
| Rigel Pharmaceuticals (RIGL) | 0.7 | $3.2M | 1.4M | 2.23 | |
| Neuroderm Ltd F | 0.7 | $3.2M | 196k | 16.25 | |
| Aviragen Therapeutics | 0.6 | $2.8M | 2.0M | 1.40 | |
| Tokai Pharmaceuticals | 0.6 | $2.8M | 511k | 5.51 | |
| Agile Therapeutics | 0.6 | $2.7M | 361k | 7.61 | |
| Esperion Therapeutics (ESPR) | 0.5 | $2.2M | 220k | 9.88 | |
| Paratek Pharmaceuticals | 0.4 | $1.9M | 134k | 13.91 | |
| Zogenix | 0.4 | $1.7M | 215k | 8.05 |
